Since altered DUB activity is associated with many cancer-associated processes, and DUB inhibition provides another opportunity for targeting currently undruggable proteins, extensive efforts are being made to develop potent and specific DUB inhibitors. The gene discussed is ZUP1; the disease is cancer.